Goldman Sachs resumes coverage on Incyte (NASDAQ: INCY) with a Buy rating and a price target of $160.00.Analyst Salveen Richter ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE